Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults
- PMID: 37582630
- PMCID: PMC11062480
- DOI: 10.1136/thorax-2022-218670
Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults
Abstract
Rationale: Electronic cigarette (e-cigarette) aerosol contains volatile aldehydes, including flavourings and oxidant metals with known pulmonary toxicity.
Objectives: To evaluate the associations of e-cigarette use with symptoms of wheeze, bronchitic symptoms and shortness of breath (SOB) across 4 years of prospective data.
Methods: Participants completed questionnaires on respiratory symptoms and past 30-day e-cigarette, cigarette and cannabis use in 2014 (wave 1; N=2094; mean age 17.3 years, SD=0.6 years). Follow-up information was collected in 2015 (wave 2; n=1609), 2017 (wave 3; n=1502) and 2018 (wave 4; n=1637) using online surveys. Mixed-effects logistic regression models evaluated associations of e-cigarette use with respiratory symptoms.
Measurements and main results: Participants were mostly Hispanic white (51.8%) and evenly representative by sex (49.6% female; 50.4% male). Compared with never e-cigarette users, past 30-day e-cigarette users reported increased odds of wheeze (OR 1.81; 95% CI 1.28, 2.56), bronchitic symptoms (OR 2.06; 95% CI 1.58, 2.69) and SOB (OR 1.78; 95% CI 1.23, 2.57), adjusting for study wave, age, sex, race, lifetime asthma diagnosis and parental education. Effect estimates were attenuated (wheeze (OR 1.41; 95% CI 0.99, 2.01), bronchitic symptoms (OR 1.55; 95% CI 1.18, 2.05), SOB (OR 1.48; 95% CI 1.01, 2.18)), after adjusting additionally for current cigarette use, cannabis use and secondhand exposure to e-cigarettes/cigarettes/cannabis.
Conclusions: E-cigarette use in young adults was associated with respiratory symptoms, independent of combustible cannabis and cigarette exposures.
Keywords: Tobacco and the lung.
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Assessment of Nicotine and Cannabis Vaping and Respiratory Symptoms in Young Adults.JAMA Netw Open. 2020 Dec 1;3(12):e2030189. doi: 10.1001/jamanetworkopen.2020.30189. JAMA Netw Open. 2020. PMID: 33351085 Free PMC article.
-
Secondhand nicotine vaping at home and respiratory symptoms in young adults.Thorax. 2022 Jul;77(7):663-668. doi: 10.1136/thoraxjnl-2021-217041. Epub 2022 Jan 10. Thorax. 2022. PMID: 35013000 Free PMC article.
-
Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study.Respir Res. 2020 Nov 16;21(1):300. doi: 10.1186/s12931-020-01569-9. Respir Res. 2020. PMID: 33198741 Free PMC article.
-
Electronic Cigarette Use and Respiratory Symptoms in Adolescents.Am J Respir Crit Care Med. 2017 Apr 15;195(8):1043-1049. doi: 10.1164/rccm.201604-0804OC. Am J Respir Crit Care Med. 2017. PMID: 27806211 Free PMC article.
-
E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States.Prev Med. 2021 Dec;153:106766. doi: 10.1016/j.ypmed.2021.106766. Epub 2021 Aug 19. Prev Med. 2021. PMID: 34418439 Free PMC article.
Cited by
-
Vaping Possible Negative Effects on Lungs: State-of-the-Art From Lung Capacity Alteration to Cancer.Cureus. 2024 Oct 22;16(10):e72109. doi: 10.7759/cureus.72109. eCollection 2024 Oct. Cureus. 2024. PMID: 39574999 Free PMC article. Review.
-
Multidisciplinary approaches in electronic nicotine delivery systems pulmonary toxicology: emergence of living and non-living bioinspired engineered systems.Commun Eng. 2024 Sep 3;3(1):123. doi: 10.1038/s44172-024-00276-3. Commun Eng. 2024. PMID: 39227652 Free PMC article. Review.
-
Tobacco and Nicotine Products Adverse Health Events: Findings From the FDA Safety Reporting Portal.Tob Use Insights. 2024 Aug 28;17:1179173X241279674. doi: 10.1177/1179173X241279674. eCollection 2024. Tob Use Insights. 2024. PMID: 39220628 Free PMC article.
-
Longitudinal associations between exclusive, dual and polytobacco use and respiratory illness among youth.BMC Public Health. 2024 Aug 8;24(1):2159. doi: 10.1186/s12889-024-19582-8. BMC Public Health. 2024. PMID: 39118071 Free PMC article.
-
Current perspective on e-cigarette use and respiratory outcomes: mechanisms and messaging.Expert Rev Respir Med. 2024 Aug;18(8):597-609. doi: 10.1080/17476348.2024.2387090. Epub 2024 Aug 11. Expert Rev Respir Med. 2024. PMID: 39101843 Review.
References
-
- Choi BM, Abraham I. The Decline in e-Cigarette Use Among Youth in the United States—An Encouraging Trend but an Ongoing Public Health Challenge. JAMA Network Open. 2021;4(6):e2112464-e. - PubMed
-
- Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, et al. Flavoring chemicals in e-cigarettes: diacetyl, 2, 3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environmental health perspectives. 2016;124(6):733–9. - PMC - PubMed
-
- Lee MS, LeBouf RF, Son YS, Koutrakis P, Christiani DC. Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco- and menthol-flavored e-cigarettes. Environ Health. 2017;16(1):42. Epub 2017/04/30. doi: 10.1186/s12940-017-0249-x. PubMed PMID: 28449666; PubMed Central PMCID: PMCPMC5406907. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous